{
  "id": "60281e461cb411341a0000f4",
  "type": "summary",
  "question": "What is the mechanism of action of Gemogenovatucel-T?",
  "ideal_answer": "Gemogenovatucel-T is an autologous tumour cell vaccine manufactured from harvested tumour tissue, which specifically reduces expression of furin and downstream TGF-\u03b21 and TGF-\u03b22.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/33271095"
  ],
  "snippets": [
    {
      "text": "Gemogenovatucel-T is an autologous tumour cell vaccine manufactured from harvested tumour tissue, which specifically reduces expression of furin and downstream TGF-\u03b21 and TGF-\u03b22. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33271095",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: Gemogenovatucel-T is an autologous tumour cell vaccine manufactured from harvested tumour tissue, which specifically reduces expression of furin and downstream TGF-\u03b21 and TGF-\u03b22.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33271095",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: Gemogenovatucel-T is an autologous tumour cell vaccine manufactured from harvested tumour tissue, which specifically reduces expression of furin and downstream TGF-\u03b21",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33271095",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: Gemogenovatucel-T is an autologous tumour cell vaccine manufactured from harvested tumour tissue, which specifically reduces expression of furin and downstream TGF-\u03b21 and TGF-\u03b22",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33271095",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}